Failure to alleviate symptoms of schizophrenia with the novel use of an antiviral agent, acyclovir (Zovirax)
Authors:
- Lynn E. DeLisiLDLynn E. DeLisi
- Lynn R. GoldinLGLynn R. Goldin
- John I. NurnbergerJNJohn I. Nurnberger
- Susan Simmons-AllingSSSusan Simmons-Alling
- Joel HamovitJHJoel Hamovit
- C.Wesley DingmanCDC.Wesley Dingman
- 28 February 1987
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 22 (2) , 216-220
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Herpes simplex virus, cytomegalovirus and Epstein–Barr virus antibody titres in sera from schizophrenic patientsPsychological Medicine, 1986
- A Survey of Serum Antibodies to Eight Common Viruses in Psychiatric PatientsThe British Journal of Psychiatry, 1985
- The biochemistry and mechanism of action of acyclovirJournal of Antimicrobial Chemotherapy, 1983
- IS SCHIZOPHRENIA AN INFECTIOUS DISEASE?The Lancet, 1983
- Schizophreniform episode with infectious mononucleosisPsychosomatics, 1982
- Antibodies to Epstein-Barr virus, herpes simplex type 1, cytomegalovirus and measles virus in psychiatric patientsArchives of Virology, 1981
- Amantadine-associated recurrence of psychosisAmerican Journal of Psychiatry, 1980
- Psychiatric and neurologic sequelae of infectious mononucleosisAmerican Journal of Psychiatry, 1978
- Anxiety and Depression After Infectious MononucleosisThe British Journal of Psychiatry, 1976
- Suppression of Herpetic Recurrence by ChlorpromazineNew England Journal of Medicine, 1975